TY  - JOUR
AU  - García-Donas, Jesús
AU  - Beuselinck, Benoit
AU  - Inglada-Pérez, Lucía
AU  - Graña, Osvaldo
AU  - Schöffski, Patrick
AU  - Wozniak, Agnieszka
AU  - Bechter, Oliver
AU  - Apellániz-Ruiz, Maria
AU  - Leandro-García, Luis Javier
AU  - Esteban, Emilio
AU  - Castellano, Daniel E
AU  - González Del Alba, Aranzazu
AU  - Climent, Miguel Angel
AU  - Hernando, Susana
AU  - Arranz, José Angel
AU  - Morente, Manuel
AU  - Pisano, David G
AU  - Rodriguez Antona, Cristina
AU  - Robledo, Mercedes
PY  - 2016
DO  - 10.1172/jci.insight.86051
SN  - 2379-3708
UR  - http://hdl.handle.net/20.500.12105/17506
AB  - The majority of metastatic renal cell carcinoma (RCC) patients are treated with tyrosine kinase inhibitors (TKI) in first-line treatment; however, a fraction are refractory to these antiangiogenic drugs. MicroRNAs (miRNAs) are regulatory molecules...
LA  - eng
PB  - American Society for Clinical Investigation (ASCI)
KW  - Adult
KW  - Aged
TI  - Deep sequencing reveals microRNAs predictive of antiangiogenic drug response.
TY  - journal article
ER  -